Speakers and chairs

Mark Roberts

Peer Coordinator - North East & North Cumbria, The Hepatitis C Trust

INSIGHT Survey

Philippe Bonnet

Harm Reduction Coordinator - Birmingham, The Hepatitis C Trust

Alternative NSP Delivery

Mark Napier

Managing Director, The Centre for Public Innovation

Understanding NSP provision in London - findings from a mapping exercise

Farrah Hart

Consultant in Public Health, Greater London Authority

Understanding NSP provision in London - findings from a mapping exercise

Monica Desai

Consultant Epidemiologist and Head of the Hepatitis Section, UK Health Security Agency

The National Picture

Amelia Andrews

Principal Scientist, Drugs & Infections team, UK Health Security Agency

The National Picture

Niamh Eastwood

Executive Director, Release

Uncracking the legality of paraphernalia laws: the case for reform

Cara Lavan

Councillor for St George Central ward, Bristol, Bristol City Council (Green Party)

Anyone's Child

Catherine Cook

Executive Director, Harm Reduction International (HRI)

Protecting Progress: Harm Reduction, Hepatitis C Elimination and the UK’s Global Leadership

Jenny Scott (she/her)

Senior Lecturer and Pharmacist Prescriber, Centre for Academic Primary Care, University of Bristol · Turning Point

Session chair

Optimising Opioid Medication-Assisted Treatment to Reduce Drug-Related Harm

Seba (she/they)

Welfare & Trans Harm Reduction Specialist Worker, Safe Only CIC

What can we learn from Queer Community Harm Reduction Practices?

Clyne Hamilton-Daniels (he/him)

Doctoral Researcher in Public Health & Policy, Queen Mary University of London

Pleasure, Platforms and Public Health: Rethinking Harm Reduction in Chemsex

Shayla Schlossenberg (they/them)

Head of Drugs Services, Release

Session chair

Chairing a session

Prof Magdalena Harris

Professor of Inclusion Health Sociology, London School of Hygiene & Tropical Medicine

Working in collaboration to improve health outcomes for people who use crack cocaine: Findings from the Safe Inhalation Pipe Provision study (SIPP)

Dr Michael Kelleher

Consultant Addictions Psychiatrist & Clinical Lead, Lambeth Addictions; National Clinical Advisor, Drugs Policy, Evidence and Delivery, DHSC - South London and Maudsley NHS Foundation Trust / Dept. of Health and Social Care

What can we offer stimulant users as treatment?

Deb Hussey

Harm Reduction Lead, Exchange Supplies

Against the Grain: The Impact of Bristol’s Harm Reduction Ethos

Dr Saket Priyadarshi

Associate Medical Director, NHS Greater Glasgow and Clyde Alcohol and Drug Recovery Services

The Thistle: The UK’s first sanctioned Drug Consumption Facility

Chelsea Shover-Darling

Associate Professor, David Geffen School of Medicine - UCLA

Participant and client perspectives on a hypothetical overdose prevention centre in Bristol: Results from qualitative interviews during a local spice overdose crisis

Reg Straub

The Hepatitis C Trust

SWERVE - peer delivered NSP and naloxone

Isabelle Boisvert (she/her)

Researcher & Partnerships Lead with Lived Experience, CRCHUM / CRISM - Quebec Node

Peer-Led Strategies for Equitable Engagement of People Who Use Drugs in Care and Research

Peter Furlong

National Harm Reduction Lead, Change Grow Live

Why we need separate, and separately funded, harm reduction and treatment services

Chris Rintoul

Head of Harm Reduction, Cranstoun

Why we need separate, and separately funded, harm reduction and treatment services

Adam Holland (he/him)

Public Health Researcher / Public Health Consultant (FFPH), University of Bristol

‘Drugs: It’s Complicated’ - Co-developing and Evaluating Films Intended to Reduce Stigma Towards People Who Use Criminalised Drugs

Victoria (Vicki) Beere

PhD Candidate, University of Manchester

We are Fearless Women: Examining the Impact of New Public Management on Women’s Access to Harm Reduction Services in England

Dilesh Popat

National Diverse Communities Lead, Turning Point

Breaking Barriers, Not Building Services Around Them - A Community Approach to Harm Reduction

Prun Bijral (he/him)

Executive Medical Director, Change Grow Live

Optimising Opioid Medication-Assisted Treatment: Reducing Drug-Related Harm through the AAAQ Framework

Rebecca Bulmer

Senior Peer Educator / Peer Researcher, The Hepatitis C Trust

The Power of Peer Research

Mark Gillyon-Powell

Deputy Director - Viral Hepatitis Elimination, Liver, Health Inequalities @ NHS England

Considering HCV Reinfection

Julia Sheehan

National Women’s Criminal Justice Manager, The Hepatitis C Trust

Through the Gate: Improving Women’s Health Outcomes Through Continuity of Care

Gavin Jones

Head of Operations, GDAS; Harm Reduction Lead, Kaleidoscope

Looking to the Past to Create a Better Future - Bringing Oral Diamorphine Treatment to Wales

Louise Hansford

BDP Trustee & Hep C Elimination Coordinator, BDP & Hep C U Later

The Role of Harm Reduction in Hepatitis C Elimination

Dean Acreman

Project Team Manager - Drugs, Threats, Harms and Trends; WEDINOS Operational Manager

WEDINOS: A market insight from open access drug testing

AJ Erikson

Youth Rise

Gen Z & The Future of Harm Reduction- young people’s perspectives: a conversation about grassroots community action, harm reduction in youth work, challenging existing systems and the meaningful involvement of young people in research and practice.

Cerys Tudor

Youth Rise

Gen Z & The Future of Harm Reduction- young people’s perspectives: a conversation about grassroots community action, harm reduction in youth work, challenging existing systems and the meaningful involvement of young people in research and practice.

Mat Southwell

Managing & Technical Director, Coact

Ketamine - from crisis to co-production